China is a big pharmaceutical industry country and has been played the role of raw material supplier in global pharmaceutical industry chain for a long time. With the overall recovery of global economy, the steady recovery of international pharmaceutical market demand, the further optimization of China's pharmaceutical export structure, the rapid development of a new generation of technology and the constant standardization of the pharmaceutical industry, pharmaceutical development situation is undergoing positive changes. It is understood that in 2017, the export volume of drug in Chinese mainland was about USD 3,100,000,000, and the export volume of drug was increased constantly. Facing the complex international supply chain and strict laws and regulations, to explore the effective countermeasures of pharmaceutical enterprises in China for coping with the barriers is the key to enhance the international market competitiveness and share of Chinese drug.

Acctrue Technology focus on the exported drug market and always brings good news of contract signing 

      In 2018, Acctrue Technology integrated the internal and external resources, optimized the technical structure and further explored the exported drug market. By means of advanced technology, rich experience, stable products and mature solutions, Acctrue Technology has successfully provided product serialization construction service to many pharmaceutical enterprises such as Hengrui, Minsheng Binjiang and HANSOH to export drug to the United States and EU.

      Recently, Acctrue Technology cooperated with many pharmaceutical enterprises such as Yiling Wanzhou International Pharmaceutical Co., Ltd., SINOPHARM ZHIJUN (Shenzhen) Pharmaceutical Co., Ltd. and CSPC Ouyi Pharmaceutical Co., Ltd., provided customized technical solutions for different enterprises, fully met the national requirements for information traceability construction, guaranteed the quality safety of the exported drug and improved the international market competitiveness.

Upgrading the globalization strategy with great strength 

      Acctrue Technology has deeply ploughed in the field of drug tagging and traceability for dozens of years, with rich experience in implementation and service. The tagging system is applicable to various serialization tagging production lines, realizes seamless docking with multiple L4 system service providers and has successfully provided the whole industry chain traceability service for many foreign-funded pharmaceutical enterprises such as Pfizer, Bayer, AstraZeneca, CSL Behring, Octapharma and Grifols.

      As the leader of whole industry chain traceability system in China, Acctrue Technology achieved strategic cooperation with TraceLink, the first drug whole industry chain traceability cloud service provider in the world in the first half of 2018. In addition, Acctrue Technology created the win-win Level1-5 all-round and one-stop drug safety and digital supply chain solution in the fields of drug digital supply chain and global compliance management in Asia-Pacific region based on its great localization technical strength, industrial background and the influence of Tracelink in drug supply chain in the world.

      In future, Acctrue will walk at the forefront of Chinese medicine traceability field continuously, deeply know the global pharmaceutical laws and regulations, construct the traceability system for pharmaceutical enterprises based on GS1 international coding standard, adapt to the traceability requirements and government rules of many countries such as China, the United States, Korea and EU and assist Chinese pharmaceutical enterprises for the globalization progress.

      Acctrue will never stop its steps on the innovation and development road and always provide “industry chain + one-stop” digitalization traceability service for all enterprises.